BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36764525)

  • 1. Loss of Splicing Factor SRSF3 Impairs Lipophagy Through Ubiquitination and Degradation of Syntaxin17 in Hepatocytes.
    Li Y; Wang T; Liao Q; Luo X; Wang X; Zeng S; You M; Chen Y; Ruan XZ
    J Lipid Res; 2023 Mar; 64(3):100342. PubMed ID: 36764525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of splicing factor SRSF3 contributes to progressive liver disease.
    Kumar D; Das M; Sauceda C; Ellies LG; Kuo K; Parwal P; Kaur M; Jih L; Bandyopadhyay GK; Burton D; Loomba R; Osborn O; Webster NJ
    J Clin Invest; 2019 Aug; 129(10):4477-4491. PubMed ID: 31393851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.
    Du J; Ji X; Xu B; Du Q; Li Y; Zhou B; Liu X; Xu Z; Jiang Y; Kou B; Li Z; Cui C; Lin J
    Metabolism; 2024 Mar; 152():155769. PubMed ID: 38158076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
    Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
    Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
    Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
    Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
    Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
    Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
    Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
    J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice.
    Wang J; Kainrad N; Shen H; Zhou Z; Rote P; Zhang Y; Nagy LE; Wu J; You M
    Am J Pathol; 2018 Aug; 188(8):1807-1819. PubMed ID: 29870742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Autophagic Flux by the 20S Proteasome.
    Njomen E; Tepe JJ
    Cell Chem Biol; 2019 Sep; 26(9):1283-1294.e5. PubMed ID: 31327703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
    Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
    J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lee DH; Park SH; Ahn J; Hong SP; Lee E; Jang YJ; Ha TY; Huh YH; Ha SY; Jeon TI; Jung CH
    Autophagy; 2021 Sep; 17(9):2415-2431. PubMed ID: 33078654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
    Mastoridou EM; Goussia AC; Kanavaros P; Charchanti AV
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma.
    Webster NJG; Kumar D; Wu P
    Sci Rep; 2024 Jan; 14(1):2500. PubMed ID: 38291075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
    Han YH; He XM; Jin MH; Sun HN; Kwon T
    Biochem Biophys Res Commun; 2023 Sep; 672():36-44. PubMed ID: 37336123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy and Lipid Droplets in the Liver.
    Martinez-Lopez N; Singh R
    Annu Rev Nutr; 2015; 35():215-37. PubMed ID: 26076903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
    Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-Induced Endoplasmic Reticulum Stress Impairs Selective Autophagy at the Step of Autophagosome-Lysosome Fusion in Hepatocytes.
    Miyagawa K; Oe S; Honma Y; Izumi H; Baba R; Harada M
    Am J Pathol; 2016 Jul; 186(7):1861-1873. PubMed ID: 27157992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of lipophagy in liver disorders.
    Nazeer B; Khawar MB; Khalid MU; Hamid SE; Rafiq M; Abbasi MH; Sheikh N; Ali A; Fatima H; Ahmad S
    Mol Cell Biochem; 2024 Jan; 479(1):1-11. PubMed ID: 36943663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIPK2A promotes STX17- and VAMP7-mediated autophagosome-lysosome fusion by binding to VAMP7B.
    Tian X; Zheng P; Zhou C; Wang X; Ma H; Ma W; Zhou X; Teng J; Chen J
    Autophagy; 2020 May; 16(5):797-810. PubMed ID: 31251111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.